Bis((Z)-but-2-enedioic acid);[7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methanamine
CAS No.:
Cat. No.: SC251559
Available on Request
Price on Request
Contact us for pricing, MOQ, and lead time
Product Name :Bis((Z)-but-2-enedioic acid);[7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methanamine
Cat. No.: :SC251559
Purity / Specification :—
CAS No. :59469-29-3
MDL No. :—
Molecular Formula :C24H23ClFN3O8
LogP :2.49
Molecular Weight :535.91
TPSA :200.0
Category :API Impurities
HSN Code :—
SMILES Code :C1N=C(C2=C(NC1CN)C=CC(=C2)Cl)C3=CC=CC=C3F.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O
Melting Point :—
InChI Key : :LYSTWDNEOGELCU-SPIKMXEPSA-N
Boiling Point :No data available
Application Note
AI GeneratedGenerated by AI. Verify before use in regulatory documents.
Lipinski & ADMET Properties
Computational estimateLipinski Rule of 5
iMW ≤ 500 Da✗ 535.9 Da
LogP ≤ 5✓ 2.49
HBD ≤ 5✗ 6
HBA ≤ 10✗ 12
Max 1 violation allowed for oral bioavailability.
Drug-likeness Score
i40/100
Fragment / low drug-likeness
Predicted LogP
i2.49log units
Optimal range (0–3)
CNS Permeability
iClark model · J Pharm Sci, 1999
CNS− unlikely
TPSA 200.0Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−
Requires experimental confirmation.
⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.
